TEMOZOLOMIDE Side Effects

7021617-4 | Arrhythmia, Asthenia, Convulsion, Disorientation, Dyspnoea, Hypocapnia, Lung Disorder, Mental Disorder, Nervous System Disorder
on Sep 23, 2010 Female patient from POLAND , 64 years of age, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), asthenia, convulsion, disorientation, dyspnoea, hypocapnia, lung disorder, mental disorder, nervous system disorder. Temozolomide dosage: 140 Mg; 280 Mg; Qd; 340 Mg; Qd .

7020371-X | Abdominal Pain, Anaemia, Asthenia, Blood Lactic Acid Increased, Decreased Appetite, Dehydration, Fatigue, Haematoma, Hypotension
Patient was taking Temozolomide (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, asthenia, blood lactic acid increased, decreased appetite, dehydration, fatigue, haematoma, hypotension on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 183.0 lb, was diagnosed with glioblastoma multiforme and. Temozolomide dosage: Po. During the same period patient was treated with ABT 888 (20 Mg;qd;po) (View Abt-888 Review and Abt-888 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ZYFLAMEND (View Zyflamend Review and Zyflamend Label ), VACCINIUM MACROCARPON (View Vaccinium Macrocarpon Review and Vaccinium Macrocarpon Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ). Patient was hospitalized.

7008733-8 | Ammonia Increased, Anaemia, Blood Thyroid Stimulating Hormone Decreased, Brain Herniation, Cachexia, Cerebral Haemorrhage, Cholestasis, Dehydration
Adverse event was reported on Sep 14, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: 100 Mg;qd) was diagnosed with glioblastoma and. Location: GERMANY , 66 years of age, weighting 92.15 lb, After Temozolomide was administered, patient had the following side effects: ammonia increased, anaemia, blood thyroid stimulating hormone decreased, brain herniation, cachexia, cerebral haemorrhage, cholestasis, dehydration. During the same period patient was treated with FORTECORTIN (CON.) (View Fortecortin (con.) Review and Fortecortin (con.) Label ), ATACAND (CON.) (View Atacand (con.) Review and Atacand (con.) Label ), FEMOSTON (CON.) (View Femoston (con.) Review and Femoston (con.) Label ), MAGNESIUM (CON.) (View Magnesium (con.) Review and Magnesium (con.) Label ), FALKAMIN (CON.) (View Falkamin (con.) Review and Falkamin (con.) Label ), URSODEOXYCHOLIC ACID (CON.) (View Ursodeoxycholic Acid (con.) Review and Ursodeoxycholic Acid (con.) Label ), KONAKION (CON.) (View Konakion (con.) Review and Konakion (con.) Label ). Patient was hospitalized.

7008730-2 | Acute Respiratory Distress Syndrome, Leukopenia, Lymphopenia, Pneumonia
on Jul 23, 2010 Male patient from SPAIN , 64 years of age, weighting 147.7 lb, was diagnosed with glioblastoma and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, leukopenia, lymphopenia, pneumonia (What is pneumonia?). Temozolomide dosage: 85 Mg; Po. During the same period patient was treated with IRINOTECAN HCL (170 Mg;qd;iv) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), DEXAMETHASONE (CON.) (View Dexamethasone (con.) Review and Dexamethasone (con.) Label ), LEVETIRACETAM (CON.) (View Levetiracetam (con.) Review and Levetiracetam (con.) Label ). Patient was hospitalized.


6969496-5 | Herpes Zoster
on Sep 07, 2010 Male patient from UNITED STATES , weighting 234.6 lb, was treated with Temozolomide (View Usage). Patient had the following side effects: herpes zoster. Temozolomide dosage: 4620 Mg. During the same period patient was treated with CELEBREX (16800 Mg) (View Celebrex Review and Celebrex Label ), ISOTRETINOIN (3780 Mg) (View Isotretinoin Review and Isotretinoin Label ). Patient was hospitalized.

6959380-5 | Pneumonia, Pulmonary Embolism
Patient was taking Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?) on Aug 31, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 192.7 lb, . Temozolomide dosage: 1750 Mg. Patient was hospitalized.

6959023-0 | Dehydration, Diarrhoea, Dizziness, Liver Function Test Abnormal, Petechiae, Thrombocytopenia, Urinary Tract Infection
Adverse event was reported on Aug 23, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: 245 Mg; Qd; Po) was diagnosed with ovarian cancer and. Location: UNITED STATES , 53 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, dizziness (What is dizziness?), liver function test abnormal, petechiae, thrombocytopenia, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with ABT 888 (40 Mg; Qd; Po) (View Abt-888 Review and Abt-888 Label ), VICODIN (View Vicodin Review and Vicodin Label ), TYLOX (View Tylox Review and Tylox Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PROCHLORPERAZINE EDISYLATE (View Prochlorperazine Edisylate Review and Prochlorperazine Edisylate Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

6958372-X | Decreased Appetite, Nausea
on Aug 30, 2010 Male patient from UNITED STATES , weighting 215.4 lb, was treated with Temozolomide (View Usage). Patient had the following side effects: decreased appetite, nausea (What is nausea?). Temozolomide dosage: 2200 Mg. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

6946367-1 | Acute Myeloid Leukaemia, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Bronchopulmonary Aspergillosis, Cerebral Haemorrhage, Malignant Neoplasm Progression, Mental Status Changes, Thrombocytopenia
on Aug 19, 2010 Female patient from UNITED STATES , 60 years of age, weighting 141.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopulmonary aspergillosis, cerebral haemorrhage, malignant neoplasm progression, mental status changes, thrombocytopenia. Temozolomide dosage: 245 Mg; Qd; Po. During the same period patient was treated with ABT 888 (20 Mg; Bid; Po, 40 Mg; Bid; Po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (20 Mg; Bid; Po, 40 Mg; Bid; Po) (View Abt-888 Review and Abt-888 Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMICAR (View Amicar Review and Amicar Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ). Patient was hospitalized.

6942072-6 | Asthenia, Dehydration, Fatigue, Pulmonary Embolism, Septic Shock, Thrombosis
Patient was taking Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dehydration, fatigue, pulmonary embolism (What is pulmonary embolism?), septic shock, thrombosis on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, was diagnosed with glioblastoma multiforme and. Temozolomide dosage: Po. During the same period patient was treated with ABT 888 (Po) (View Abt-888 Review and Abt-888 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ZYFLAMEMD (View Zyflamemd Review and Zyflamemd Label ), VACCINIUM MACROCARPON (View Vaccinium Macrocarpon Review and Vaccinium Macrocarpon Label ), ASCROBIC ACID (View Ascrobic Acid Review and Ascrobic Acid Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ). Patient was hospitalized.

6938398-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Brain Oedema, Brain Scan Abnormal, Chest Discomfort, Condition Aggravated, Confusional State, Headache, Hyperglycaemia
Adverse event was reported on Aug 11, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: 140 Mg;qd;po) was diagnosed with glioblastoma and. Location: KOREA, REPUBLIC OF , 62 years of age, weighting 168.4 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain oedema, brain scan abnormal, chest discomfort, condition aggravated, confusional state, headache (What is headache?), hyperglycaemia. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6931442-8 | Acute Myeloid Leukaemia, Bronchopulmonary Aspergillosis, Cerebellar Haemorrhage, Depressed Level Of Consciousness, Malignant Neoplasm Progression, Mental Status Changes, Pneumonia, Thrombocytopenia
on Aug 13, 2010 Female patient from UNITED STATES , 60 years of age, weighting 141.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: acute myeloid leukaemia, bronchopulmonary aspergillosis, cerebellar haemorrhage, depressed level of consciousness, malignant neoplasm progression, mental status changes, pneumonia (What is pneumonia?), thrombocytopenia. Temozolomide dosage: 245 Mg, Qd. Po. During the same period patient was treated with ABT 888 (20 Mg, Bid, Po; 40 Mg, Bid, Po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (20 Mg, Bid, Po; 40 Mg, Bid, Po) (View Abt-888 Review and Abt-888 Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMICAR (View Amicar Review and Amicar Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ). Patient was hospitalized.

6929172-1 | Asthenia, Dehydration, Fatigue, Pulmonary Embolism, Septic Shock, Thrombosis
on Aug 09, 2010 Male patient from UNITED STATES , 72 years of age, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dehydration, fatigue, pulmonary embolism (What is pulmonary embolism?), septic shock, thrombosis. Temozolomide dosage: ;po. During the same period patient was treated with ABT 888 (;po) (View Abt-888 Review and Abt-888 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ZYFLAMEND (View Zyflamend Review and Zyflamend Label ), VACCINIUM MACROCARPON (View Vaccinium Macrocarpon Review and Vaccinium Macrocarpon Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ). Patient was hospitalized.

6928338-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Tachycardia, Brain Oedema, Brain Scan Abnormal, Confusional State, Headache, Hyperglycaemia, Myocardial Ischaemia
Patient was taking Temozolomide (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial tachycardia, brain oedema, brain scan abnormal, confusional state, headache (What is headache?), hyperglycaemia, myocardial ischaemia on Aug 06, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 62 years of age, weighting 168.4 lb, was diagnosed with glioblastoma and. Temozolomide dosage: 140 Mg;qd;po. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6927746-5 | Acute Myeloid Leukaemia, Cerebral Haemorrhage, Depressed Level Of Consciousness, Hypoxia, Malignant Neoplasm Progression, Mental Status Changes, Pneumonia, Thrombocytopenia
Adverse event was reported on Aug 09, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: 245 Mg;qd;po) was diagnosed with myeloma recurrence and. Location: UNITED STATES , 60 years of age, weighting 141.2 lb, After Temozolomide was administered, patient had the following side effects: acute myeloid leukaemia, cerebral haemorrhage, depressed level of consciousness, hypoxia, malignant neoplasm progression, mental status changes, pneumonia (What is pneumonia?), thrombocytopenia. During the same period patient was treated with ABT 888 (20 Mg;bid;po; 40 Mg;bid;po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (20 Mg;bid;po; 40 Mg;bid;po) (View Abt-888 Review and Abt-888 Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMICAR (View Amicar Review and Amicar Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ). Patient was hospitalized.

6925555-4 | Brain Oedema, Face Injury, Fall, Glioblastoma, Haematoma, Malignant Neoplasm Progression, Neurological Decompensation
on Jul 30, 2010 Male patient from SPAIN , 54 years of age, was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, face injury, fall (What is fall?), glioblastoma, haematoma, malignant neoplasm progression, neurological decompensation. Temozolomide dosage: 17 Mg/m2. During the same period patient was treated with IRINOTECAN HCL (100 Mg/m2) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), EMCONCOR (View Emconcor Review and Emconcor Label ), NORVASC (View Norvasc Review and Norvasc Label ), SUTRIL (View Sutril Review and Sutril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6920277-8 | Acute Myeloid Leukaemia, Cerebral Haemorrhage, Malignant Neoplasm Progression, Mental Status Changes, Pneumonia
on Aug 04, 2010 Female patient from UNITED STATES , 60 years of age, weighting 141.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Temozolomide (View Usage). Patient had the following side effects: acute myeloid leukaemia, cerebral haemorrhage, malignant neoplasm progression, mental status changes, pneumonia (What is pneumonia?). Temozolomide dosage: Qd; Po. During the same period patient was treated with ABT 888 (Bid; Po, Bid; Po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (Bid; Po, Bid; Po) (View Abt-888 Review and Abt-888 Label ), ACYCLOVIR (CON.) (View Acyclovir (con.) Review and Acyclovir (con.) Label ), ALLOPURINOL (CON.) (View Allopurinol (con.) Review and Allopurinol (con.) Label ), AMICAR (CON.) (View Amicar (con.) Review and Amicar (con.) Label ), AZTREONAM (CON.) (View Aztreonam (con.) Review and Aztreonam (con.) Label ), CARVEDILOL (CON.) (View Carvedilol (con.) Review and Carvedilol (con.) Label ), MOXIFLOXACIN (CON.) (View Moxifloxacin (con.) Review and Moxifloxacin (con.) Label ). Patient was hospitalized.

6918219-4 | Dehydration, Diarrhoea, Dizziness, Liver Function Test Abnormal, Thrombocytopenia
Patient was taking Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: dehydration, diarrhoea, dizziness (What is dizziness?), liver function test abnormal, thrombocytopenia on Aug 02, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 130.1 lb, was diagnosed with ovarian cancer and. Temozolomide dosage: Po. During the same period patient was treated with ABT 888 (40 Mg;qd;po) (View Abt-888 Review and Abt-888 Label ), VICODIN (View Vicodin Review and Vicodin Label ), TYLOX (View Tylox Review and Tylox Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PROCHLORPERAZINE EDISYLATE (View Prochlorperazine Edisylate Review and Prochlorperazine Edisylate Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ). Patient was hospitalized.

6916054-4 | Acute Myeloid Leukaemia, Hypoxia, Leukaemia Recurrent, Pneumonia
Adverse event was reported on Jul 30, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: Qd;po) was diagnosed with acute myeloid leukaemia, leukaemia recurrent and. Location: UNITED STATES , 60 years of age, weighting 141.2 lb, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, hypoxia, leukaemia recurrent, pneumonia (What is pneumonia?). During the same period patient was treated with ABT 888 (Bid;po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (Bid;po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (Bid;po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (Bid;po) (View Abt-888 Review and Abt-888 Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMICAR (View Amicar Review and Amicar Label ). Patient was hospitalized.

6913444-0 | Bronchitis, Cough
on Jul 29, 2010 Male patient from FRANCE , child 5 years of age, weighting 37.04 lb, was diagnosed with medulloblastoma recurrent and was treated with Temozolomide (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), cough. Temozolomide dosage: 55 Mg; Qd; Po. During the same period patient was treated with IRINOTECAN HCL (5.5 Mg; Qd; Iv) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), JOSACINE (View Josacine Review and Josacine Label ). Patient was hospitalized.

6909404-6 | Brain Oedema, Hemiparesis, Intracranial Pressure Increased, Psychomotor Retardation, Somnolence
on Jul 28, 2010 Female patient from FRANCE , 64 years of age, weighting 163.1 lb, was diagnosed with glioblastoma and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: brain oedema, hemiparesis, intracranial pressure increased, psychomotor retardation, somnolence. Temozolomide dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6895347-3 | Confusional State, Fall, Hyponatraemia, Incontinence
Patient was taking Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, fall (What is fall?), hyponatraemia, incontinence on Jul 30, 2010 from CANADA Additional patient health information: Male patient , weighting 127.4 lb, . Temozolomide dosage: 1250 Mg. Patient was hospitalized.

6882020-0 | Clostridium Difficile Colitis, Decreased Appetite, Failure To Thrive, Fatigue, Pancytopenia, Thrombocytopenia
Adverse event was reported on Jul 28, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: 135 Mg Daily Po) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , weighting 151.5 lb, Patient had the following side effects: clostridium difficile colitis, decreased appetite, failure to thrive, fatigue, pancytopenia, thrombocytopenia. During the same period patient was treated with PACLITAXEL (73 Mg Wkly X 4 Doses Iv) (View Paclitaxel Review and Paclitaxel Label ).

6881415-9 | Convulsion, Urticaria
on Jul 28, 2010 Female patient from UNITED STATES , weighting 194.4 lb, was diagnosed with glioblastoma and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: convulsion, urticaria. Temozolomide dosage: 185mg Daily X 21 Days Po. Patient was hospitalized.

6881394-4 | Atrial Fibrillation, Convulsion, Electrocardiogram St Segment Abnormal, Electrocardiogram T Wave Abnormal, Ventricular Extrasystoles
on Jul 28, 2010 Male patient from UNITED STATES , weighting 249.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), convulsion, electrocardiogram st segment abnormal, electrocardiogram t wave abnormal, ventricular extrasystoles. Temozolomide dosage: 230mg Daily Oral. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), DYASIDE (View Dyaside Review and Dyaside Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6881393-2 | Neurological Decompensation
Patient was taking Temozolomide (View Usage). Patient had the following side effects: neurological decompensation on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 194.4 lb, was diagnosed with glioblastoma and. Temozolomide dosage: 185 Mg Daily X 21 Days Po.

6881391-9 | Convulsion, Craniotomy, Malignant Neoplasm Progression
Adverse event was reported on Jul 28, 2010 by a Male patient taking Temozolomide (View Usage) (Dosage: 185mg (100mg/m^2) Daily 21 Days/28dys Po) was diagnosed with glioblastoma and. Location: UNITED STATES , weighting 191.0 lb, After Temozolomide was administered, patient had the following side effects: convulsion, craniotomy, malignant neoplasm progression. Patient was hospitalized.

6881390-7 | Methaemoglobinaemia, Pyrexia, Syncope
on Jul 28, 2010 Female patient from UNITED STATES , weighting 172.4 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, pyrexia, syncope. Temozolomide dosage: 190 Mg Qd Oral. During the same period patient was treated with SENNA (View Senna Review and Senna Label ). Patient was hospitalized.

6881389-0 | Asthenia, Colitis Ulcerative, Deep Vein Thrombosis, Fall, Gout, Hypoglycaemia, Malignant Neoplasm Progression, Pulmonary Embolism, Pyrexia
on Jul 28, 2010 Male patient from UNITED STATES , weighting 220.5 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient had the following side effects: asthenia, colitis ulcerative, deep vein thrombosis (What is deep vein thrombosis?), fall (What is fall?), gout (What is gout?), hypoglycaemia, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?), pyrexia. Temozolomide dosage: 220 Mg Daily Oral. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6881387-7 | Asthenia, Dysarthria, Fatigue, Hypoaesthesia, Malignant Neoplasm Progression, Viith Nerve Paralysis
Patient was taking Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: asthenia, dysarthria, fatigue, hypoaesthesia, malignant neoplasm progression, viith nerve paralysis on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 218.7 lb, was diagnosed with glioblastoma and. Temozolomide dosage: 210 Mg Qd Daily. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6874764-1 | Dehydration, Diarrhoea, Dizziness, Liver Function Test Abnormal, Urinary Tract Infection
Adverse event was reported on Jul 19, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: Po) was diagnosed with ovarian cancer and. Location: UNITED STATES , 53 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, dizziness (What is dizziness?), liver function test abnormal, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with ABT 888 (40 Mg;qd;po) (View Abt-888 Review and Abt-888 Label ), VICODIN (View Vicodin Review and Vicodin Label ), TYLOX (View Tylox Review and Tylox Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), PROCHLORPERAZINE EDISYLATE (View Prochlorperazine Edisylate Review and Prochlorperazine Edisylate Label ). Patient was hospitalized.

6869445-4 | Confusional State, Fall, Hyponatraemia, Incontinence
on Jul 22, 2010 Male patient from CANADA , weighting 127.4 lb, was treated with Temozolomide (View Usage). Patient had the following side effects: confusional state, fall (What is fall?), hyponatraemia, incontinence. Temozolomide dosage: 1250 Mg. Patient was hospitalized.

6862414-X | Hepatitis Fulminant
on Jul 12, 2010 Female patient from CHILE , 37 years of age, weighting 163.1 lb, was diagnosed with astrocytoma and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: hepatitis fulminant. Temozolomide dosage: Qd ; Qd. During the same period patient was treated with LEVETIRACETAM (Q12h) (View Levetiracetam Review and Levetiracetam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ). Patient was hospitalized.

6848385-0 | Arthralgia, Bone Pain, Fatigue, Febrile Neutropenia, Haemoglobin Decreased, Liver Function Test Abnormal, Thrombocytopenia
Patient was taking Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, bone pain, fatigue, febrile neutropenia, haemoglobin decreased, liver function test abnormal, thrombocytopenia on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 125.7 lb, was diagnosed with glioblastoma multiforme and. Temozolomide dosage: Po. During the same period patient was treated with ABT 888 (10 Mg;qd;po, 10 Mg;bid;po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (10 Mg;qd;po, 10 Mg;bid;po) (View Abt-888 Review and Abt-888 Label ), DUCOSATE SODIUM (View Ducosate Sodium Review and Ducosate Sodium Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

6843467-1 | Hepatitis Fulminant
Adverse event was reported on Jul 05, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: ) was diagnosed with astrocytoma and. Location: CHILE , 36 years of age, Patient had the following side effects: hepatitis fulminant.

6842240-8 | Bone Marrow Toxicity, Platelet Count Decreased
on Jul 02, 2010 Female patient from GREECE , 69 years of age, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: bone marrow toxicity, platelet count decreased. Temozolomide dosage: ; Po. Patient was hospitalized.

6831623-8 | Bone Marrow Toxicity
on Jun 30, 2010 Female patient from GREECE , 69 years of age, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow toxicity. Temozolomide dosage: Po. Patient was hospitalized.

6830733-9 | Asthenia, Failure To Thrive, Neutropenia, Thrombocytopenia, Unevaluable Event
Patient was taking Temozolomide (View Usage). Patient had the following side effects: asthenia, failure to thrive, neutropenia, thrombocytopenia, unevaluable event on Jul 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 151.5 lb, was diagnosed with glioblastoma multiforme and. Temozolomide dosage: 135 Mg Daily Po. During the same period patient was treated with PACLITAXEL (73 Mg Wkly X 4 Doses Iv) (View Paclitaxel Review and Paclitaxel Label ), PENTAMIDINE ISETHIONATE (View Pentamidine Isethionate Review and Pentamidine Isethionate Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

6830731-5 | Neutropenia, Thrombocytopenia
Adverse event was reported on Jul 09, 2010 by a Male patient taking Temozolomide (View Usage) (Dosage: 75mg/m2 Daily Po) was diagnosed with gliosarcoma and. Location: UNITED STATES , weighting 136.7 lb, After Temozolomide was administered, patient had the following side effects: neutropenia, thrombocytopenia. During the same period patient was treated with PACLITAXEL (40mg/m2 Wkly X6 Iv) (View Paclitaxel Review and Paclitaxel Label ), KEPPRA (View Keppra Review and Keppra Label ), PENTAMIDINE ISETHIONATE (View Pentamidine Isethionate Review and Pentamidine Isethionate Label ). Patient was hospitalized.

6818771-3 | Dehydration, Glioblastoma, Malignant Neoplasm Progression, Platelet Count Decreased
on Jun 24, 2010 Female patient from UNITED STATES , 58 years of age, weighting 151.2 lb, was diagnosed with glioblastoma and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, glioblastoma, malignant neoplasm progression, platelet count decreased. Temozolomide dosage: . During the same period patient was treated with RAD001C (420mg) (View Rad001c Review and Rad001c Label ). Patient was hospitalized.

6799039-0 | Arthralgia, Bone Pain, Febrile Neutropenia, Haemoglobin Decreased, Liver Function Test Abnormal, Refusal Of Treatment By Patient, Thrombocytopenia, White Blood Cell Count Decreased
on Jun 21, 2010 Female patient from UNITED STATES , 63 years of age, weighting 125.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient had the following side effects: arthralgia, bone pain, febrile neutropenia, haemoglobin decreased, liver function test abnormal, refusal of treatment by patient, thrombocytopenia, white blood cell count decreased. Temozolomide dosage: Po. During the same period patient was treated with ABT 888 (10 Mg, Qd;po, 10 Mg;bid;po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (10 Mg, Qd;po, 10 Mg;bid;po) (View Abt-888 Review and Abt-888 Label ), DUCOSATE SODIUM (CON.) (View Ducosate Sodium (con.) Review and Ducosate Sodium (con.) Label ), OXYCODONE (CON.) (View Oxycodone (con.) Review and Oxycodone (con.) Label ), DEXAMETHASONE (CON.) (View Dexamethasone (con.) Review and Dexamethasone (con.) Label ), LANSOPRAZOLE (CON.) (View Lansoprazole (con.) Review and Lansoprazole (con.) Label ), ZOLPIDEM TARTRATE (CON.) (View Zolpidem Tartrate (con.) Review and Zolpidem Tartrate (con.) Label ), ACETYLSALICYLIC ACID (CON.) (View Acetylsalicylic Acid (con.) Review and Acetylsalicylic Acid (con.) Label ). Patient was hospitalized.

6798313-1 | Lymphopenia, Pneumonia
Patient was taking Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: lymphopenia, pneumonia (What is pneumonia?) on Jun 16, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with non-small cell lung cancer and. Temozolomide dosage: 125 Mg; Qd. During the same period patient was treated with SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TYLENOL (View Tylenol Review and Tylenol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), VITAMIN B1 TAB (View Vitamin B1 Tab Review and Vitamin B1 Tab Label ). Patient was hospitalized.

6797893-X | Arthralgia, Bone Pain, Febrile Neutropenia, Haemoglobin Decreased, Liver Function Test Abnormal, Refusal Of Treatment By Patient, Thrombocytopenia, White Blood Cell Count Decreased
Adverse event was reported on Jun 16, 2010 by a Female patient taking Temozolomide (View Usage) (Dosage: ; Po) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 63 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, bone pain, febrile neutropenia, haemoglobin decreased, liver function test abnormal, refusal of treatment by patient, thrombocytopenia, white blood cell count decreased. During the same period patient was treated with ABT 888 (10 Mg; Qd; Po, 10 Mg; Bid; Po) (View Abt-888 Review and Abt-888 Label ), ABT 888 (10 Mg; Qd; Po, 10 Mg; Bid; Po) (View Abt-888 Review and Abt-888 Label ), DUCOSATE SODIUM (View Ducosate Sodium Review and Ducosate Sodium Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6781018-0 | Pneumonia
on Jun 17, 2010 Male patient from UNITED STATES , weighting 251.5 lb, was treated with Temozolomide (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Temozolomide dosage: 2300 Mg. Patient was hospitalized.

6773576-7 | Anaemia, Dysphagia, Hypophosphataemia, Leukopenia, Local Swelling, Lymphadenitis, Lymphopenia, Mastication Disorder, Neutropenia
on Jun 07, 2010 Male patient from UNITED STATES , 18 years of age, was diagnosed with medulloblastoma recurrent and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: anaemia, dysphagia, hypophosphataemia, leukopenia, local swelling, lymphadenitis, lymphopenia, mastication disorder, neutropenia. Temozolomide dosage: 180 Mg/m2; Qd; Po. During the same period patient was treated with ABT 888 (15 Mg/m2; Bid; Po) (View Abt-888 Review and Abt-888 Label ). Patient was hospitalized.

6770276-4 | Arthralgia, Bone Pain, Febrile Neutropenia, Liver Function Test Abnormal, Thrombocytopenia
Patient was taking Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, bone pain, febrile neutropenia, liver function test abnormal, thrombocytopenia on Jun 07, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 125.7 lb, was diagnosed with glioblastoma multiforme and. Temozolomide dosage: Po. During the same period patient was treated with ABT 888 (10 Mg; Qd; Po 10 Mg; Bid) (View Abt-888 Review and Abt-888 Label ), ABT 888 (10 Mg; Qd; Po 10 Mg; Bid) (View Abt-888 Review and Abt-888 Label ), DUCOSATE SODIUM (View Ducosate Sodium Review and Ducosate Sodium Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6769564-7 | Abdominal Pain Upper, Aortic Dilatation, Blood Culture Positive, Chest Pain, Diarrhoea, Diastolic Dysfunction, Duodenitis, Febrile Neutropenia, Gastric Haemorrhage
Adverse event was reported on Jun 02, 2010 by a Male patient taking Temozolomide (View Usage) (Dosage: 285 Mg; Qd; Po, 380 Mg; Qd; Po) was diagnosed with metastatic malignant melanoma and. Location: UNITED KINGDOM , 65 years of age, Patient had the following side effects: abdominal pain upper, aortic dilatation, blood culture positive, chest pain (What is chest pain?), diarrhoea, diastolic dysfunction, duodenitis, febrile neutropenia, gastric haemorrhage. During the same period patient was treated with FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ). Patient was hospitalized.

6768910-8 | Aspartate Aminotransferase Increased, Fatigue, Lung Infiltration, Lymphopenia, Pneumonitis
on May 26, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). After Temozolomide was administered, patient had the following side effects: aspartate aminotransferase increased, fatigue, lung infiltration, lymphopenia, pneumonitis. Temozolomide dosage: . Patient was hospitalized.

6755516-X | Pneumonia
on May 19, 2010 Male patient from KOREA, REPUBLIC OF , 48 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Temozolomide dosage: 120 Mg; Po; 250 Mg; Po; 330 Mg Po. Patient was hospitalized.

6754822-2 | Dysphagia, Mucosal Inflammation, Nausea, Neutropenia, Oral Candidiasis, Oropharyngeal Pain, Productive Cough, Pyrexia
Patient was taking Temozolomide (View Usage). Patient had the following side effects: dysphagia, mucosal inflammation, nausea (What is nausea?), neutropenia, oral candidiasis, oropharyngeal pain, productive cough, pyrexia on May 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 60 years of age, weighting 205.0 lb, was diagnosed with metastatic malignant melanoma and. Temozolomide dosage: ; Po. During the same period patient was treated with CYCLIZINE (View Cyclizine Review and Cyclizine Label ), CODANTHRAMER (View Codanthramer Review and Codanthramer Label ), METOCLORPAMIDE (View Metoclorpamide Review and Metoclorpamide Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), STEMETIL /00013301/ (View Stemetil /00013301/ Review and Stemetil /00013301/ Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.